GlassScriptPhysician profile
Bhaskar Bhardwaj
NPI 1922428143
$35,486.23
in general payments reported to CMS, 2019-2025
27 companies · $1,356 in 2025
The $1,356 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $2,360 · 2021: $25K · 2022: $1,689 · 2023: $2,206 · 2024: $2,414 · 2025: $1,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,298 · Travel and Lodging: $2,678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,297.88 |
| Travel and Lodging | $2,677.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25,411.78 | 2021-2025 | Micra, Corevalve Evolut R, Resolute Onyx |
| Edwards Lifesciences Corporation | $3,059.90 | 2019-2024 | Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $2,112.95 | 2020 | |
| Abbott Laboratories | $1,930.97 | 2019-2025 | Navitor, Cardiomems, Amplatzer Talisman |
| Shockwave Medical, INC | $1,120.49 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $434.51 | 2022-2025 | Impella |
| Boston Scientific Corporation | $277.76 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $185.32 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $149.78 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $140.19 | 2023 | Lifevest |
| Biosense Webster, INC. | $136.19 | 2025 | Nuvision Ice Catheter |
| Lexicon Pharmaceuticals, INC. | $127.86 | 2023-2024 | Inpefa |
| Novartis Pharmaceuticals Corporation | $80.40 | 2022-2023 | |
| Penumbra, INC. | $49.95 | 2025 | Indigo System |
| Getinge USA Sales, LLC | $45.71 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $35.66 | 2023-2024 | Xarelto |
| Maquet Cardiovascular L.L.C. | $26.31 | 2019 | |
| Philips North America LLC | $19.30 | 2024 | (6536) Phoenix |
| E.R. Squibb & Sons, L.L.C. | $18.96 | 2024 | Camzyos |
| Alnylam Pharmaceuticals INC. | $18.83 | 2024 | Amvuttra |
| Silk Road Medical, INC. | $17.75 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Kiniksa Pharmaceuticals, LTD. | $16.97 | 2023 | Arcalyst |
| Pfizer INC. | $15.23 | 2025 | |
| Chiesi USA, INC. | $14.11 | 2025 | Kengreal |
| Merck Sharp & Dohme LLC | $13.58 | 2023 | Verquvo |
| Terumo Medical Corporation | $13.04 | 2023 | Glidesheath Slender, Glidewire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.73 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhaskar Bhardwaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.